Clinical Trials

78 enrolled

Carcinoma, Renal Cell, Neoplasms

NCT06860386 2026-03-06

Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC

Phase 2 Suspended

75 enrolled

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT07123090 2026-02-27

SPARCC

25 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT05805501 2026-02-12

A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma

199 enrolled

Carcinoma, Renal Cell

NCT05327686 2026-01-14

SAMURAI

240 enrolled

Carcinoma, Renal Cell

NCT03092856 2025-12-17

Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer

62 enrolled

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT07277972 2025-12-11

Iparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic Therapy

36 enrolled

Carcinoma, Renal Cell

NCT03595124 2025-12-03

A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC)

15 enrolled 15 charts

Carcinoma, Renal Cell

NCT04370509 2025-11-19

Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery

6 enrolled 11 charts

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT07172386 2025-09-16

Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCC

40 enrolled

Carcinoma, Renal Cell

NCT05969496 2025-04-04

NEOPAX

17 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT05256472 2025-03-06

A Study of AK104 Monotherapy or AK104 Plus Axitinib in Advanced/Metastatic Renal Cell Carcinoma

70 enrolled

Carcinoma, Renal Cell

NCT06211114 2024-11-26

Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma

30 enrolled

Carcinoma, Renal Cell

NCT01693822 2024-11-21

A-PREDICT

65 enrolled 15 charts

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT02639182 2024-11-18

A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

133 enrolled 35 charts

Carcinoma, Renal Cell

NCT06690697 2024-11-15

Combination of Toripalimab and JS004 Therapy for ccRCC

80 enrolled

Carcinoma, Renal Cell

NCT02579811 2023-06-29

Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer

40 enrolled 12 charts

Carcinoma, Renal Cell, Neoplasms

NCT05817903 2023-05-08

AxIn

118 enrolled

Carcinoma, Renal Cell

NCT02489695 2022-09-06

AXIPAP

44 enrolled

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT05263609 2022-08-02

Optimizing Pembrolizumab Therapy With Timing and Intensification With Axitinib

Phase 2 Withdrawn

Carcinoma, Renal Cell

NCT01649180 2021-08-12

PrE0801

3 enrolled 7 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04995016 2021-08-06

PANDORA

Phase 2 Unknown

18 enrolled

Carcinoma, Renal Cell

NCT04958473 2021-07-12

SAARCC

Phase 2 Unknown

40 enrolled

Carcinoma, Renal Cell

NCT03494816 2021-06-30

NAXIVA

24 enrolled 11 charts

Carcinoma, Renal Cell

NCT01798446 2020-12-08

A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus

41 enrolled

Carcinoma, Renal Cell

NCT00569946 2019-06-05

Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC)

64 enrolled 17 charts

Carcinoma, Renal Cell

NCT01441414 2019-01-08

PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma

18 enrolled 10 charts

Carcinoma, Renal Cell

NCT02560012 2018-10-12

Personalized Targeted Inhibitors Treatment in Renal Cell Cancer

4 enrolled 3 charts

Carcinoma, Renal Cell

NCT03341845 2018-05-21

Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC

Phase 2 Unknown

40 enrolled

Carcinoma, Renal Cell

NCT00835978 2017-05-30

Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer

213 enrolled 29 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00282048 2012-07-31

Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer

62 enrolled 12 charts